KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Accounts Payables (2016 - 2025)

Neogenomics (NEO) has disclosed Accounts Payables for 16 consecutive years, with $23.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables rose 6.86% year-over-year to $23.1 million, compared with a TTM value of $23.1 million through Dec 2025, up 6.86%, and an annual FY2025 reading of $23.1 million, up 6.86% over the prior year.
  • Accounts Payables was $23.1 million for Q4 2025 at Neogenomics, up from $22.6 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $28.5 million in Q3 2021 and bottomed at $13.7 million in Q3 2022.
  • Average Accounts Payables over 5 years is $20.0 million, with a median of $19.6 million recorded in 2021.
  • The sharpest move saw Accounts Payables skyrocketed 60.9% in 2021, then tumbled 51.96% in 2022.
  • Year by year, Accounts Payables stood at $17.9 million in 2021, then grew by 14.45% to $20.5 million in 2022, then dropped by 0.86% to $20.3 million in 2023, then rose by 6.26% to $21.6 million in 2024, then increased by 6.86% to $23.1 million in 2025.
  • Business Quant data shows Accounts Payables for NEO at $23.1 million in Q4 2025, $22.6 million in Q3 2025, and $27.5 million in Q2 2025.